Outcome Following Platelet Rich Plasma Injection In Patients Of Chronic Lateral Epicondylitis
Abstract
Background: Various modalities of management are available for lateral epicondylitis which is a common cause of pain around elbow. Many studies have suggested the use of prp (platelet rich plasma) as a safe and effective mode of therapy.
Material and Methods: purpose of this study was to assess the efficacy of prp injection in patients of chronic lateral epicondylitis.It was an interventional study of 70 cases with at least 6 months of symptoms and failed conventional therapy. PRP was prepared from 40 ml autologous venous blood by double centrifugation method.Patients were followed upto 6months. An analysis of result with regards to pain (vas score) was done.
Results: Right elbow was predominantly affected in our sample. Mean age of patients was 41 years. Success was defined as reduction of pain (vas) without re-intervention after a follow up of 6 months. In all patients there was improvement in vas score .pre injection mean vas score of patients was 7.04 and at final follow-up it was 1.84. There was 74 % improvement in vas score. There was progressive improvement with no complications.
Conclusion: Treatment of patients with tennis elbow with prp decreases pain and significantly increases function, even after a follow-up of 6 months.
Downloads
References
Tenotomy).
Emilo Lopez Vidriero, Krista A. Goulding, David A. Simon, Mikel Sanchez
and Donald H. Johnson. The Use of Platelet-Rich Plasma in Arthroscopy and
Sports Medicine: Optimizing the Healing Environment. The Journal of
Arthroscopic and Related Surgery 2010; Vol 26, No 2 (February): 269-278
Carol A. Autologous Platelet Concentrate for the Production of Platelet Gel. Januar 2007.
Eppley B, Woodell JE, Higgins J. Platelet quantification and growth factor
analysis from platelet-rich plasma: Implications for wound healing. Plast
ReconstrSurg 2004;114:1502-1508.
Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts
for musculoskeletal injuries: A review. Curr Rev Musculoskelet Med
;1:165-174.
Scott, A. And Ashe, M.C.(2006) Common tendinopathies in the upper and lower extremities.
Current Sports Medicine Reports 5,233-241
Forde, M.S., Punnett, L. and Wegman, H.. (2005) Prevalence of
musculoskeletal disorders in union ironworkers. Journal of Occupational and
Environmental Hygiene 2, 203-212.
Nirschl RP et al Elbow tendinopathy : Tennis elbow,clin sports Med. 2003 oct(4) : 813-36.
Karen Walker-Bone ,Keith T Palmer and Cyrus Cooper : Occupation and Epicondylitis : A
population based study, Rheumatology(Oxford).2012 Feb. ;51(2) :305-310.
Ciccoti MG, Lombardo SJ. Lateral and medial epicondylitis of the elbow.
In: Jobe FW, Pin MM, Glousman RE et al editors. Operative techniques in upper extremity
sports injuries. St. Louis(MO): Mosby-Year Book; 1996.p.431-46.
Aron Gonshor, Technique for Producing Platelet-Rich Plasma and Platelet
Concentrate: Background and Process. The International Journal of
Periodontics and Restorative Dentistry. 2002 , Volume 22, 6.
Pietrzak, W.S. and Eppley, B.L. Platelet rich plasma: Biology and new
technology. J CraniofacSurg, 2005: 16, 1043.
Mishra and Pavelko. Treatment of chronic elbow tendinosis with buffered
platelet-rich plasma. Am J Sports Med. 10(10):1–5, 2006.
Jonathan T. Finnoff , DO, Steven P. Fowler, MD, Jim K. Lai, Paula J.
Santrach, MD, Elaine A. Willis, RN, BSN, Yusef A. Sayeed, MD, MPH, Jay
Smith, MD Treatment of Chronic Tendinopathy with Ultrasound-Guided
Needle Tenotomy and Platelet-Rich Plasma Injection. PM R 2011;3:900-911.
Ragab EM, Othman AM Platelets rich plasma for treatment of chronic plantar
fasciitis. Arch Orthop Trauma Surg. 2012 Aug;132(8):1065-70.
Kevin Lutsky et al Hand Dominance and common Hand Conditions 151.
The entire contents of the Orthopaedic Journal of Madhya Pradesh Chapter are protected under Indian and International copyrights. Orthopaedic Journal of Madhya Pradesh Chapter allow authors to retain the copyrights of their papers without restrictions, Authors grant the publisher the right of exclusive publication. The Journal then grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship. The journal also grants the right to make numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Non-commercial share alike 4.0 International Public License.